CMC & Product Quality
Innovation in CMC (Chemistry, Manufacturing and Controls) is at the heart of the pharmaceutical industry. Advances in regulatory practice and novel approaches to supply are key to this topic. This track will provide insights into how manufacturers and regulators can collaborate to deliver this revolution without risks to the supply of medicines.
Who is This Track Designed For?
This track is recommended for regulatory affairs, manufacturing, supply chain, quality assurance, and other professionals who want to keep up to date with the most recent developments in regulatory science and technology impacting CMC/GMP related activities.
Topic Leader
Mark Pellett
Senior Director and Group Manager
AstraZeneca, United Kingdom
Sarah Miksinski
Executive Director, CMC Regulatory Affairs
Gilead Sciences